NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
Related Articles
- NKF Spring Clinical Meeting Home Dialysis Posters Posted 04-23-2025
- Visit the MEI Booth (#100) at the Upcoming ANNA National Symposium Posted 04-23-2025
- The National Kidney Foundation has Updated Two of its Home Dialysis Resources Posted 03-13-2025
- See How Outset Medical is Bringing Home HD into Skilled Nursing Facilities Posted 03-13-2025